Just thinking about the spin and effect on gnbt sh
Post# of 36536
NGIO has all the potential right now. GNBT has a bunch of acquisitions that appear to all be operating at a loss. GNBT has not closed on ALTuCELL. The NGIO shares are only a valuable asset for GNBT if they are listed and holding 70% of the shares would certainly benefit GNBT but you cannot just add the NGIO share price to GNBT. They will only own 70% and GNBT will continue to operate at a loss unless/until the buildout of the AZ project is complete AND successful or GNBT closes on and ALTuCELL announces a trial or AE37 enters phase 3. Excellagen will not be able to do it alone and Pantheon and Regentes, well, I don’t know what they are doing.
NGIO listing or a Covid vac are the only things that will move this pps and keep it up. Anything else will not hold. /my opinion